Verve Collaborative Health

Verve Collaborative Health in Omaha, Nebraska is a Spravato (esketamine) treatment center for adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions. This FDA-approved nasal spray, made from ketamine, regulates neuron activity to reactivate areas of the brain affected by depression, and can reduce symptoms in as little as 24 hours rather than the weeks typical of traditional antidepressants.

Clients self-administer the nasal spray at the center and are monitored by medical staff for one to two hours afterward. Most begin with twice-weekly doses for the first month, reducing to once weekly, with many finding relief after about three months of treatment.

The practice has a team of psychiatric mental health nurse practitioners, and works with insurance companies to verify Spravato coverage.